$10.47
0.85% today
NYSE, Apr 02, 09:20 pm CET
ISIN
US98888T1079
Symbol
ZIMV
Sector

ZimVie Stock price

$10.56
-2.92 21.66% 1M
-5.15 32.78% 6M
-3.39 24.30% YTD
-7.91 42.83% 1Y
-13.42 55.96% 3Y
-17.44 62.29% 5Y
-17.44 62.29% 10Y
NYSE, Closing price Tue, Apr 01 2025
-0.24 2.22%
ISIN
US98888T1079
Symbol
ZIMV
Sector

Key metrics

Market capitalization $292.27m
Enterprise Value $449.87m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 60.06
EV/Sales (TTM) EV/Sales 1.00
P/S ratio (TTM) P/S ratio 0.65
P/B ratio (TTM) P/B ratio 0.77
Revenue growth (TTM) Revenue growth -41.31%
Revenue (TTM) Revenue $449.75m
EBIT (operating result TTM) EBIT $-2.02m
Free Cash Flow (TTM) Free Cash Flow $7.49m
Cash position $74.97m
EPS (TTM) EPS $-0.93
P/E forward 96.84
P/S forward 0.65
EV/Sales forward 1.00
Short interest 1.83%
Show more

Is ZimVie a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

ZimVie Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a ZimVie forecast:

2x Hold
67%
1x Sell
33%

Analyst Opinions

3 Analysts have issued a ZimVie forecast:

Hold
67%
Sell
33%

Financial data from ZimVie

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
450 450
41% 41%
100%
- Direct Costs 186 186
42% 42%
41%
263 263
41% 41%
59%
- Selling and Administrative Expenses 204 204
35% 35%
45%
- Research and Development Expense 27 27
43% 43%
6%
32 32
61% 61%
7%
- Depreciation and Amortization 34 34
72% 72%
8%
EBIT (Operating Income) EBIT -2.02 -2.02
95% 95%
0%
Net Profit -26 -26
93% 93%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about ZimVie directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ZimVie Stock News

Neutral
GlobeNewsWire
8 days ago
PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.
Neutral
GlobeNewsWire
20 days ago
PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including:
Neutral
Seeking Alpha
about one month ago
ZimVie Inc. (NASDAQ:ZIMV ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS William McMahon - Barclays Operator Good afternoon and welcome to ZimVie's ...
More ZimVie News

Company Profile

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Westminster, CO.

Head office United States
CEO Vafa Jamali
Employees 1,770
Founded 2021
Website www.zimvie.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today